Featured Research

from universities, journals, and other organizations

Ovarian cancer advances when genes are silenced

Date:

December 14, 2010

Source:

Duke University Medical Center

Summary:

Researchers have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.

Share This

There are many mechanisms that alter the activity of genes - direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.

Related Articles

Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation - a mechanism for turning off genes -- in tumor cells.

The researchers performed a series of studies on cancer cell lines and primary tumor specimens from ovarian cancer patients by comparing the genome-wide gene expression profiles of cells that were treated or mock-treated with drugs that inhibit DNA methylation. From these studies they identified 378 candidate methylated genes. From this group, all 43 of the predicted genes the researchers analyzed showed methylation in ovarian cancers.

"We were very surprised to see that so many of these genes were part of one pathway, the TGF-beta signaling pathway, so we conducted studies to further explore how methylation might have an effect on the pathway," said senior author Susan Murphy, Ph.D., assistant professor in the Division of Gynecologic Oncology in Duke OB-GYN and in the Department of Pathology.

When the researchers treated tumor cells with methylation inhibitors, the TGF-beta pathway showed increased activity. This is an important signaling pathway that directs many processes in cells. A smoothly functioning TGF-beta pathway ensures proper cell growth, cell differentiation, and apoptosis (programmed cell death), and helps prevent tumor formation. When this pathway is deregulated, it can instead help tumors grow and metastasize.

The study showed for the first time that TGF-beta pathway function is regulated through methylation. "This is only one piece of a larger puzzle about the biology of ovarian cancer, but we can say that DNA methylation does have an influence on suppressing TGF-beta pathway signaling, which contributes to ovarian cancer."

In addition, the genes they studied included a cluster of genes that strongly correlated with TGF-beta pathway activity in specimens from older women, which suggested that age-related epigenetic changes can accumulate and may contribute to cancer.

Murphy said two different groups of patients the team identified might need different approaches.

"Some women with ovarian cancer have lower expression of these tumor-suppressing genes and may be amenable to epigenetic therapies that lead to gene reactivation - with the caveat that at this point we can't epigenetically reactivate just one gene or a specific group of genes," Murphy said. "Another group of women with ovarian cancer have higher expression of these genes, suggesting it may be possible to specifically inhibit particular components in this pathway to stop tumor development or progression."

The results were published in Genome Research on December 14.

Other authors included co-lead authors Noriomi Matsumura and Zhiqing Huang, Tsukasa Baba and Andrew Berchuck of the Duke Division of Gynecologic Oncology; Seiichi Mori of the Duke Institute for Genome Sciences & Policy; Edwin S. Iversen of the Duke Department of Statistical Sciences; Shingo Fujii of the National Hospital Organization Kyoto Medical Center in Kyoto, Japan; and Ikuo Konishi of the Department of Gynecology and Obstetrics in Kyoto University, Japan.

This work was supported by grants from the Department of Defense CDMRP Ovarian Cancer Research Program and the Japan Society for the Promotion of Science.

Featured Research

Mar. 31, 2015  Researchers have illuminated an important distinction between mice and humans: how human livers heal. The difference centers on a protein called PPAR alpha which activates liver ... full story

Mar. 31, 2015  Researchers have recorded the first direct observations of the micro-scale mechanisms behind the ability of skin to resist tearing. The results could be applied to the improvement of artificial skin, ... full story

Mar. 31, 2015  Fewer than half of the physicians trained in the United States in 2013 received formal education or training on the subject of exercise, according to new research. "There are immense medical benefits ... full story

Mar. 31, 2015  Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer's given an experimental cancer drug, researchers report. "With this treatment, cells under ... full story

Mar. 31, 2015  Increasing state alcohol taxes could prevent thousands of deaths a year from car crashes, say researchers, who found alcohol-related motor vehicle crashes decreased after taxes on beer, wine and ... full story

Mar. 31, 2015  Alcoholism takes a toll on every aspect of a person's life, including skin problems. Now, a new research report helps explain why this happens and what might be done to address it. "The clinical ... full story

Mar. 31, 2015  A new population of 'memory' immune cells has been discovered by scientists, throwing light on what the body does when it sees a microbe for the second time. This insight, and others like it, will ... full story

Mar. 31, 2015  Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying ... full story

Mar. 31, 2015  A new study had researchers seeking answers to why the therapeutic benefit afforded by SSRIs was so limited in children and teenagers. If researchers can uncover the biological mechanisms preventing ... full story

Featured Videos

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015)  The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports.
Video provided by Reuters

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015)  Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline.
Video provided by Washington Post

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015)  Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17
Video provided by AFP

Related Stories

Nov. 26, 2014  A deeper understanding of how KRAS turns off tumor suppressor genes and identifies a key enzyme in the process has been gained by researchers. The findings suggest that this enzyme, known as TET1, ... full story

June 17, 2014  Research into the origins of ovarian cancer has led to the discovery of a genetic pathway that could slow the spread of the cancer. The discovery is in part due to research into the genetics of ... full story

May 2, 2014  Inhibiting enzymes that cause changes in gene expression could decrease chemotherapy resistance in ovarian cancer patients, researchers say. “Ovarian cancer is usually treated by surgery followed ... full story

May 27, 2011  Five to 10 percent of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes. Researchers report on new insights into the ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.